Rare diseases
Investigational molecules
Locations
Back to Slovenia10 clinical trials in Celje, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
SloveniaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
SloveniaStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
SloveniaStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
SloveniaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
SloveniaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SloveniaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
SloveniaStudy of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
SloveniaStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
SloveniaSloveniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Multiple Sclerosis treatment, evaluating new therapeutic approaches to reduce relapse frequency and improve patient outcomes.
Comparative studies examining advanced treatment options for neurological conditions.
Groundbreaking trials in cardiovascular disease prevention and treatment, including studies on heart failure and atherosclerosis management.
Focus on reducing major cardiovascular events and improving heart function.
Comprehensive research into chronic inflammatory diseases, including Hidradenitis Suppurativa and inflammatory bowel conditions.
Testing advanced therapies for moderate to severe inflammatory disorders.
Critical studies in anticoagulation management for urgent surgical procedures and emergency medical interventions.
Evaluating innovative approaches for critical care situations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
